Download PDF
Semin Respir Crit Care Med 2011; 32(6): 663-672
DOI: 10.1055/s-0031-1295714
© Thieme Medical Publishers

Fungal Diagnostics in Pneumonia

Erika D. Lease1 , Barbara D. Alexander1
  • 1Department of Medicine, Division of Infectious Diseases and International Health, Duke University Medical Center, Durham, North Carolina
Further Information

Publication History

Publication Date:
13 December 2011 (online)

    Permissions and Reprints

ABSTRACT

Fungal pneumonia is increasingly common, particularly in highly immunosuppressed patients, such as solid organ or hematopoietic stem cell transplant recipients, and the diagnosis is evolving. Although standard techniques such as microscopy and culture remain the mainstays of diagnosis, relatively recent advances in serological and molecular testing are important additions to the field. This article reviews the laboratory tools used to diagnose fungal respiratory disease.

KEYWORDS

Fungal diagnosis - laboratory methods - fungal tests

REFERENCES

  • 1 Marr K A, Carter R A, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients.  Clin Infect Dis. 2002;  34 (7) 909-917
    Google Scholar
  • 2 De Pauw B, Walsh T J, Donnelly J P European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.  Clin Infect Dis. 2008;  46 (12) 1813-1821
    Google Scholar
  • 3 Murrary P R, Witebsky F G. The clinician and the microbiology lab. In: Mandell J L, Bennet J E, Dolin R, eds. Principles and Practice of Infectious Diseases. 7th ed. Philadelphia, PA: Churchill Livingstone; 2009: 233-265
    Google Scholar
  • 4 Harrington B J, Hageage G J. Calcofluor white: a review of its uses and applications in clinical mycology and parasitology.  Lab Med. 2003;  34 361-367
    Google Scholar
  • 5 Bennet J E. Introduction to mycoses. In: Mandell J L, Bennet J E, Dolin R, eds. Principles and Practice of Infectious Diseases. 7th ed. Philadelphia, PA: Churchill Livingstone; 2009: 3221-4
    Google Scholar
  • 6 Procop G W, Haddad S, Quinn J et al.. Detection of Pneumocystis jiroveci in respiratory specimens by four staining methods.  J Clin Microbiol. 2004;  42 (7) 3333-3335
    Google Scholar
  • 7 Tarrand J J, Lichterfeld M, Warraich I et al.. Diagnosis of invasive septate mold infections: a correlation of microbiological culture and histologic or cytologic examination.  Am J Clin Pathol. 2003;  119 (6) 854-858
    Google Scholar
  • 8 Kontoyiannis D P, Wessel V C, Bodey G P, Rolston K V. Zygomycosis in the 1990s in a tertiary-care cancer center.  Clin Infect Dis. 2000;  30 (6) 851-856
    Google Scholar
  • 9 Alexander B D, Pfaller M A. Contemporary tools for the diagnosis and management of invasive mycoses.  Clin Infect Dis. 2006;  43 S15-S27
    Google Scholar
  • 10 Balajee S A, Kano R, Baddley J W et al.. Molecular identification of Aspergillus species collected for the Transplant-Associated Infection Surveillance Network.  J Clin Microbiol. 2009;  47 (10) 3138-3141
    Google Scholar
  • 11 Clinical and Laboratory Standards Institute (CLSI) .Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi; Approved Standard Third Edition. CLSI Document M27–A3 (ISBN 1–56238–668–9). http://www.clsi.org Accessed July 25, 2011
    Google Scholar
  • 12 Clinical and Laboratory Standards Institute (CLSI) .Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi; Approved Standard Second Edition. CLSI Document M38–A2 (ISBN 1–56238–668–9). http://www.clsi.org Accessed July 25, 2011
    Google Scholar
  • 13 Pfaller M A, Diekema D J, Ghannoum M A Clinical and Laboratory Standards Institute Antifungal Testing Subcommittee et al. Wild-type MIC distribution and epidemiological cutoff values for Aspergillus fumigatus and three triazoles as determined by the Clinical and Laboratory Standards Institute broth microdilution methods.  J Clin Microbiol. 2009;  47 (10) 3142-3146
    Google Scholar
  • 14 Reed J A, Hemann B A, Alexander J L, Brigati D J. Immunomycology: rapid and specific immunocytochemical identification of fungi in formalin-fixed, paraffin-embedded material.  J Histochem Cytochem. 1993;  41 (8) 1217-1221
    Google Scholar
  • 15 Verweij P E, Smedts F, Poot T, Bult P, Hoogkamp-Korstanje J A, Meis J F. Immunoperoxidase staining for identification of Aspergillus species in routinely processed tissue sections.  J Clin Pathol. 1996;  49 (10) 798-801
    Google Scholar
  • 16 Borchers A T, Gershwin M E. The immune response in Coccidioidomycosis.  Autoimmun Rev. 2010;  10 (2) 94-102
    Google Scholar
  • 17 Wheat J, Wheat H, Connolly P et al.. Cross-reactivity in Histoplasma capsulatum variety capsulatum antigen assays of urine samples from patients with endemic mycoses.  Clin Infect Dis. 1997;  24 (6) 1169-1171
    Google Scholar
  • 18 Williams B, Fojtasek M, Connolly-Stringfield P, Wheat J. Diagnosis of histoplasmosis by antigen detection during an outbreak in Indianapolis, Ind.  Arch Pathol Lab Med. 1994;  118 (12) 1205-1208
    Google Scholar
  • 19 Wheat L J, Conces D, Allen S D, Blue-Hnidy D, Loyd J. Pulmonary histoplasmosis syndromes: recognition, diagnosis, and management.  Semin Respir Crit Care Med. 2004;  25 (2) 129-144
    Google Scholar
  • 20 Hage C A, Davis T E, Fuller D et al.. Diagnosis of histoplasmosis by antigen detection in BAL fluid.  Chest. 2010;  137 (3) 623-628
    Google Scholar
  • 21 Blair J E, Coakley B, Santelli A C, Hentz J G, Wengenack N L. Serologic testing for symptomatic coccidioidomycosis in immunocompetent and immunosuppressed hosts.  Mycopathologia. 2006;  162 (5) 317-324
    Google Scholar
  • 22 Sarosi G A, Lawrence J P, Smith D K, Thomas A, Hobohm D W, Kelley P C. Rapid diagnostic evaluation of bronchial washings in patients with suspected coccidioidomycosis.  Semin Respir Infect. 2001;  16 (4) 238-241
    Google Scholar
  • 23 DiTommaso J P, Ampel N M, Sobonya R E, Bloom J W. Bronchoscopic diagnosis of pulmonary coccidioidomycosis: comparison of cytology, culture, and transbronchial biopsy.  Diagn Microbiol Infect Dis. 1994;  18 (2) 83-87
    Google Scholar
  • 24 Durkin M, Connolly P, Kuberski T et al.. Diagnosis of coccidioidomycosis with use of the Coccidioides antigen enzyme immunoassay.  Clin Infect Dis. 2008;  47 (8) e69-e73
    Google Scholar
  • 25 Fernandes V C, Coitinho J B, Veloso JMR, Araújo S A, Pedroso E P, Goes A M. Combined use of Paracoccidioides brasiliensis recombinant rPb27 and rPb40 antigens in an enzyme-linked immunosorbent assay for immunodiagnosis of paracoccidioidomycosis.  J Immunol Methods. 2011;  367 (1-2) 78-84
    Google Scholar
  • 26 Singh N, Alexander B D, Lortholary O et al.. Pulmonary cryptococcosis in solid organ transplant recipients: clinical relevance of serum cryptococcal antigen.  Clin Infect Dis. 2008;  46 (2) e12-e18
    Google Scholar
  • 27 Kralovic S M, Rhodes J C. Utility of routine testing of bronchoalveolar lavage fluid for cryptococcal antigen.  J Clin Microbiol. 1998;  36 (10) 3088-3089
    Google Scholar
  • 28 Lyman C A, Devi SJN, Nathanson J, Frasch C E, Pizzo P A, Walsh T J. Detection and quantitation of the glucuronoxylomannan-like polysaccharide antigen from clinical and nonclinical isolates of Trichosporon beigelii and implications for pathogenicity.  J Clin Microbiol. 1995;  33 (1) 126-130
    Google Scholar
  • 29 Fekkar A, Brun S, D’Ussel M et al.. Serum cross-reactivity with Aspergillus galactomannan and cryptococcal antigen during fatal disseminated Trichosporon dermatis infection.  Clin Infect Dis. 2009;  49 (9) 1457-1458
    Google Scholar
  • 30 Platelia aspergillus EIA [package insert]. Redmond, WA: Bio-Rad Laboratories; 2003
    Google Scholar
  • 31 Pfeiffer C D, Fine J P, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis.  Clin Infect Dis. 2006;  42 (10) 1417-1427
    Google Scholar
  • 32 Park S Y, Lee S O, Choi S H et al.. Serum and bronchoalveolar lavage fluid galactomannan assays in patients with pulmonary aspergilloma.  Clin Infect Dis. 2011;  52 (7) e149-e152
    Google Scholar
  • 33 Park S Y, Lee S O, Choi S H et al.. Aspergillus galactomannan antigen assay in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis.  J Infect. 2010;  61 (6) 492-498
    Google Scholar
  • 34 Bergeron A, Belle A, Sulahian A et al.. Contribution of galactomannan antigen detection in BAL to the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies.  Chest. 2010;  137 (2) 410-415
    Google Scholar
  • 35 Nguyen M H, Leather H, Clancy C J et al.. Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients.  Biol Blood Marrow Transplant. 2011;  17 (7) 1043-1050
    Google Scholar
  • 36 Meersseman W, Lagrou K, Maertens J et al.. Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients.  Am J Respir Crit Care Med. 2008;  177 (1) 27-34
    Google Scholar
  • 37 Maertens J, Maertens V, Theunissen K et al.. Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases.  Clin Infect Dis. 2009;  49 (11) 1688-1693
    Google Scholar
  • 38 Musher B, Fredricks D, Leisenring W, Balajee S A, Smith C, Marr K A. Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid.  J Clin Microbiol. 2004;  42 (12) 5517-5522
    Google Scholar
  • 39 Becker M J, Lugtenburg E J, Cornelissen J J, Van Der Schee C, Hoogsteden H C, De Marie S. Galactomannan detection in computerized tomography-based broncho-alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis.  Br J Haematol. 2003;  121 (3) 448-457
    Google Scholar
  • 40 Pasqualotto A C, Xavier M O, Sánchez L B et al.. Diagnosis of invasive aspergillosis in lung transplant recipients by detection of galactomannan in the bronchoalveolar lavage fluid.  Transplantation. 2010;  90 (3) 306-311
    Google Scholar
  • 41 Husain S, Clancy C J, Nguyen M H et al.. Performance characteristics of the platelia Aspergillus enzyme immunoassay for detection of Aspergillus galactomannan antigen in bronchoalveolar lavage fluid.  Clin Vaccine Immunol. 2008;  15 (12) 1760-1763
    Google Scholar
  • 42 Sulahian A, Touratier S, Ribaud P. False positive test for aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam.  N Engl J Med. 2003;  349 (24) 2366-2367
    Google Scholar
  • 43 Adam O, Aupérin A, Wilquin F, Bourhis J H, Gachot B, Chachaty E. Treatment with piperacillin-tazobactam and false-positive Aspergillus galactomannan antigen test results for patients with hematological malignancies.  Clin Infect Dis. 2004;  38 (6) 917-920
    Google Scholar
  • 44 Mattei D, Rapezzi D, Mordini N et al.. False-positive Aspergillus galactomannan enzyme-linked immunosorbent assay results in vivo during amoxicillin-clavulanic acid treatment.  J Clin Microbiol. 2004;  42 (11) 5362-5363
    Google Scholar
  • 45 Hage C A, Reynolds J M, Durkin M, Wheat L J, Knox K S. Plasmalyte as a cause of false-positive results for Aspergillus galactomannan in bronchoalveolar lavage fluid.  J Clin Microbiol. 2007;  45 (2) 676-677
    Google Scholar
  • 46 Marr K A, Laverdiere M, Gugel A, Leisenring W. Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay.  Clin Infect Dis. 2005;  40 (12) 1762-1769
    Google Scholar
  • 47 Desmet S, Van Wijngaerden E, Maertens J et al.. Serum (1-3)-β-D-glucan as a tool for diagnosis of Pneumocystis jirovecii pneumonia in patients with human immunodeficiency virus infection or hematological malignancy.  J Clin Microbiol. 2009;  47 (12) 3871-3874
    Google Scholar
  • 48 Yoshida M, Obayashi T, Iwama A et al.. Detection of plasma (1 —>3)-β-D-glucan in patients with Fusarium, Trichosporon, Saccharomyces and Acremonium fungaemias.  J Med Vet Mycol. 1997;  35 (5) 371-374
    Google Scholar
  • 49 Ostrosky-Zeichner L, Alexander B D, Kett D H et al.. Multicenter clinical evaluation of the (1—>3) β-D-glucan assay as an aid to diagnosis of fungal infections in humans.  Clin Infect Dis. 2005;  41 (5) 654-659
    Google Scholar
  • 50 Odabasi Z, Mattiuzzi G, Estey E et al.. β-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome.  Clin Infect Dis. 2004;  39 (2) 199-205
    Google Scholar
  • 51 Ostrosky-Zeichner L, Alexander B D, Kett D H et al.. Multicenter clinical evaluation of the (1—>3) β-D-glucan assay as an aid to diagnosis of fungal infections in humans.  Clin Infect Dis. 2005;  41 (5) 654-659
    Google Scholar
  • 52 Pazos C, Pontón J, Del Palacio A. Contribution of (1->3)-β-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan.  J Clin Microbiol. 2005;  43 (1) 299-305
    Google Scholar
  • 53 Alexander B D, Smith P B, Davis R D, Perfect J R, Reller L B. The (1,3)β-D-glucan test as an aid to early diagnosis of invasive fungal infections following lung transplantation.  J Clin Microbiol. 2010;  48 (11) 4083-4088
    Google Scholar
  • 54 Pickering J W, Sant H W, Bowles C A, Roberts W L, Woods G L. Evaluation of a (1->3)-β-D-glucan assay for diagnosis of invasive fungal infections.  J Clin Microbiol. 2005;  43 (12) 5957-5962
    Google Scholar
  • 55 Mennink-Kersten M A, Warris A, Verweij P E. 1,3-β-D-glucan in patients receiving intravenous amoxicillin-clavulanic acid.  N Engl J Med. 2006;  354 (26) 2834-2835
    Google Scholar
  • 56 Nakao A, Yasui M, Kawagoe T, Tamura H, Tanaka S, Takagi H. False-positive endotoxemia derives from gauze glucan after hepatectomy for hepatocellular carcinoma with cirrhosis.  Hepatogastroenterology. 1997;  44 (17) 1413-1418
    Google Scholar
  • 57 Harrison E, Stalhberger T, Whelan R Aspergillus Technology Consortium (AsTeC) et al. Aspergillus DNA contamination in blood collection tubes.  Diagn Microbiol Infect Dis. 2010;  67 (4) 392-394
    Google Scholar
  • 58 Palmer J, Francesconi A, Kasai M et al.. Sources of false positive Aspergillus DNA by PCR from normal human blood. Paper presented at: 41st Interscience Conference on Antimicrobial Agents and Chemotherapy; December 16–19, 2001; Chicago, IL
    Google Scholar
  • 59 Donnelly J P. Polymerase chain reaction for diagnosing invasive aspergillosis: getting closer but still a ways to go.  Clin Infect Dis. 2006;  42 (4) 487-489
    Google Scholar
  • 60 Mengoli C, Cruciani M, Barnes R A, Loeffler J, Donnelly J P. Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis.  Lancet Infect Dis. 2009;  9 (2) 89-96
    Google Scholar
  • 61 White P L, Perry M D, Moody A, Follett S A, Morgan G, Barnes R A. Evaluation of analytical and preliminary clinical performance of Myconostica MycAssay Aspergillus when testing serum specimens for diagnosis of invasive Aspergillosis.  J Clin Microbiol. 2011;  49 (6) 2169-2174
    Google Scholar
  • 62 Hayette M P, Vaira D, Susin F et al.. Detection of Aspergillus species DNA by PCR in bronchoalveolar lavage fluid.  J Clin Microbiol. 2001;  39 (6) 2338-2340
    Google Scholar
  • 63 Tuon F F. A systematic literature review on the diagnosis of invasive aspergillosis using polymerase chain reaction (PCR) from bronchoalveolar lavage clinical samples.  Rev Iberoam Micol. 2007;  24 (2) 89-94
    Google Scholar
  • 64 Hauser P M, Bille J, Lass-Flörl C et al.. Multicenter, prospective clinical evaluation of respiratory samples from subjects at risk for Pneumocystis jirovecii infection by use of a commercial real-time PCR assay.  J Clin Microbiol. 2011;  49 (5) 1872-1878
    Google Scholar
  • 65 Balajee S A, Kano R, Baddley J W et al.. Molecular identification of Aspergillus species collected for the Transplant-Associated Infection Surveillance Network.  J Clin Microbiol. 2009;  47 (10) 3138-3141
    Google Scholar
  • 66 Hammond S P, Bialek R, Milner D A, Petschnigg E M, Baden L R, Marty F M. Molecular methods to improve diagnosis and identification of mucormycosis.  J Clin Microbiol. 2011;  49 (6) 2151-2153
    Google Scholar
  • 67 Rickerts V, Just-Nübling G, Konrad F et al.. Diagnosis of invasive aspergillosis and mucormycosis in immunocompromised patients by seminested PCR assay of tissue samples.  Eur J Clin Microbiol Infect Dis. 2006;  25 (1) 8-13
    Google Scholar
  • 68 Rickerts V, Mousset S, Lambrecht E et al.. Comparison of histopathological analysis, culture, and polymerase chain reaction assays to detect invasive mold infections from biopsy specimens.  Clin Infect Dis. 2007;  44 (8) 1078-1083
    Google Scholar
  • 69 Hayden R T, Qian X, Procop G W, Roberts G D, Lloyd R V. In situ hybridization for the identification of filamentous fungi in tissue section.  Diagn Mol Pathol. 2002;  11 (2) 119-126
    Google Scholar
  • 70 Hayden R T, Isotalo P A, Parrett T et al.. In situ hybridization for the differentiation of Aspergillus, Fusarium, and Pseudallescheria species in tissue section.  Diagn Mol Pathol. 2003;  12 (1) 21-26
    Google Scholar
  • 71 Gonzales D A, De Torre C, Wang H et al.. Protein expression profiles distinguish between experimental invasive pulmonary aspergillosis and Pseudomonas pneumonia.  Proteomics. 2010;  10 (23) 4270-4280
    Google Scholar
  • 72 Sainz J, Salas-Alvarado I, López-Fernández E et al.. TNFR1 mRNA expression level and TNFR1 gene polymorphisms are predictive markers for susceptibility to develop invasive pulmonary aspergillosis.  Int J Immunopathol Pharmacol. 2010;  23 (2) 423-436
    Google Scholar
  • 73 Loeffler J, Ok M, Morton O C, Mezger M, Einsele H. Genetic polymorphisms in the cytokine and chemokine system: their possible importance in allogeneic stem cell transplantation.  Curr Top Microbiol Immunol. 2010;  341 83-96
    Google Scholar
  • 74 Zaas A K, Liao G, Chien J W et al.. Plasminogen alleles influence susceptibility to invasive aspergillosis.  PLoS Genet. 2008;  4 (6) e1000101
    Google Scholar
  • 75 Bochud P Y, Chien J W, Marr K A et al.. Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation.  N Engl J Med. 2008;  359 (17) 1766-1777
    Google Scholar

Barbara D. AlexanderM.D. 

Department of Medicine, Division of Infectious Diseases and International Health, Duke University Medical Center

Research Dr., 116G Carl Bldg., Durham, NC 27710

Email: alexa011@mc.duke.edu

      >